Open AccessUse of low-level laser therapy as monotherapy or concomitant therapy for male and female Androgenetic alopecia
Author(s) -
Andréia Munck,
Maria Fernanda Gavazzoni,
Ralph M. Trüeb
Publication year - 2014
Publication title -
international journal of trichology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.494
H-Index - 22
eISSN - 0974-9241
pISSN - 0974-7753
DOI - 10.4103/0974-7753.138584
Subject(s) - concomitant , finasteride , medicine , combination therapy , adverse effect , laser therapy , minoxidil , pharmacotherapy , hair growth , dermatology , urology , physiology , laser , prostate , physics , cancer , optics
Androgenetic alopecia (AGA) is the most common form of hair loss in men and in women. Currently, minoxidil and finasteride are the treatments with the highest levels of medical evidence, but patients who exhibit intolerance or poor response to these treatments are in need of additional treatment modalities.